Literature DB >> 2204242

Inactivation of viral antigens for vaccine preparation with particular reference to the application of binary ethylenimine.

H G Bahnemann1.   

Abstract

Viral antigens for human and veterinary vaccines are still inactivated with formaldehyde. This is not an ideal inactivant and the problems of formaldehyde inactivation of vaccines are discussed. Vaccines inactivated with aziridines are superior in safety and antigenicity. Aziridines inactivate viruses in a first-order reaction and the inactivation rate and endpoint can be determined. The preparation and application of the aziridine compound binary ethylenimine (BEI) and the necessary conditions for and controls of the inactivation process are described and discussed. A computer program has been written for assistance in the use of BEI for controlled inactivation of viral antigens.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2204242      PMCID: PMC7173316          DOI: 10.1016/0264-410x(90)90083-x

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  25 in total

1.  Inactivation of viruses in serum with binary ethyleneimine.

Authors:  H G Bahnemann
Journal:  J Clin Microbiol       Date:  1976-02       Impact factor: 5.948

2.  The inactivation of foot-and-mouth disease virus by formalin.

Authors:  T WESSLEN; Z DINTER
Journal:  Arch Gesamte Virusforsch       Date:  1957

3.  Studies of the inactivation of poliomyelitis virus by formaldehyde; the effect upon the rate of inactivation of temperature, pH and concentration of formaldehyde.

Authors:  E LYCKE
Journal:  Arch Gesamte Virusforsch       Date:  1958

4.  [Partially inactivated poliomyelitis virus: initiation of infection in tissue culture].

Authors:  P SCHULTZ; W A RIGHTSEL; E A TIMM; A R TAYLOR; I W McLEAN
Journal:  J Immunol       Date:  1957-12       Impact factor: 5.422

5.  Immune response to virus-infection-associated (VIA) antigen in cattle repeatedly vaccinated with foot-and-mouth disease virus inactivated by formalin or acetylethyleneimine.

Authors:  A A Pinto; A J Garland
Journal:  J Hyg (Lond)       Date:  1979-02

6.  The inactivation of foot-and-mouth disease virus by ethylenimine and propylenimine.

Authors:  H G Bahnemann
Journal:  Zentralbl Veterinarmed B       Date:  1972-07

7.  [The inactivation of foot-and-mouth disease virus by ethylethyleneimine and the use of the inactivated virus in the preparation of vaccines].

Authors:  K Bauer
Journal:  Zentralbl Bakteriol Orig       Date:  1970-04

8.  Comparison of the inactivation and antigenicity of foot-and-mouth-disease virus by acetylethyleneimine and by combined effect of ultraviolet light and beta-propiolactone.

Authors:  O N Fellowes
Journal:  J Immunol       Date:  1965-12       Impact factor: 5.422

9.  Formaldehyde inactivation of foot-and-mouth disease virus. Conditions for the preparation of safe vaccine.

Authors:  S J Barteling; R Woortmeyer
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

10.  A preliminary vaccine potency trial of a Newcastle disease virus inactivated with binary ethylenimine.

Authors:  C Buonavoglia; A Fioretti; M Tollis; F Menna; V Papparella
Journal:  Vet Res Commun       Date:  1988       Impact factor: 2.459

View more
  48 in total

1.  Genetical and immunological analysis of recent Asian type A and O foot-and-mouth disease virus isolates.

Authors:  B Freiberg; M M Rahman; O Marquardt
Journal:  Virus Genes       Date:  1999       Impact factor: 2.332

2.  Molecular identification of the vaccine strain from the inactivated oil emulsion H9N2 low pathogenic avian influenza vaccine.

Authors:  Jun Gu Choi; Youn Jeong Lee; Ji Yeon Kim; Yeon Hee Kim; Mi Ra Paek; Dong Kun Yang; Seong Wan Son; Jae Hong Kim
Journal:  J Vet Sci       Date:  2010-06       Impact factor: 1.672

3.  Immune responses and protective efficacy of binary ethylenimine (BEI)-inactivated bluetongue virus vaccines in sheep.

Authors:  M A Ramakrishnan; A B Pandey; K P Singh; R Singh; S Nandi; M L Mehrotra
Journal:  Vet Res Commun       Date:  2006-11       Impact factor: 2.459

4.  Plasmid DNA encoding replicating foot-and-mouth disease virus genomes induces antiviral immune responses in swine.

Authors:  G Ward; E Rieder; P W Mason
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

5.  Truncation and sequence shuffling of segment 6 generate replication-competent neuraminidase-negative influenza H5N1 viruses.

Authors:  Donata Kalthoff; Susanne Röhrs; Dirk Höper; Bernd Hoffmann; Jessica Bogs; Jürgen Stech; Martin Beer
Journal:  J Virol       Date:  2013-10-09       Impact factor: 5.103

6.  An inactivated vaccine from a field strain of bovine herpesvirus-1 (BoHV-1) has high antigenic mass and induces strong efficacy in a rabbit model.

Authors:  Julian Ruiz-Sáenz; Jairo Jaime; Victor Vera
Journal:  Virol Sin       Date:  2013-02-06       Impact factor: 4.327

7.  Protective humoral immune response induced by an inactivated porcine reproductive and respiratory syndrome virus expressing the hypo-glycosylated glycoprotein 5.

Authors:  Jung-Ah Lee; Byungjoon Kwon; Fernando A Osorio; Asit K Pattnaik; Nak-Hyung Lee; Sang-Won Lee; Seung-Yong Park; Chang-Seon Song; In-Soo Choi; Joong-Bok Lee
Journal:  Vaccine       Date:  2014-05-09       Impact factor: 3.641

8.  Inactivation of human cytomegalovirus by sodium periodate oxidation.

Authors:  F Geoffroy; G Ogier; J Chantepie; G Quash
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

9.  Inactivation of infectious bursal disease virus by binary ethylenimine and formalin.

Authors:  M Habib; I Hussain; W H Fang; Z I Rajput; Z Z Yang; H Irshad
Journal:  J Zhejiang Univ Sci B       Date:  2006-04       Impact factor: 3.066

10.  New vaccine design based on defective genomes that combines features of attenuated and inactivated vaccines.

Authors:  Teresa Rodríguez-Calvo; Samuel Ojosnegros; Marta Sanz-Ramos; Juan García-Arriaza; Cristina Escarmís; Esteban Domingo; Noemí Sevilla
Journal:  PLoS One       Date:  2010-04-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.